Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study is a Post-Marketing Surveillance study to evaluate the safety and efficacy of
bimatoprost/timolol (Ganfort®) Ophthalmic Solution to treat open-angle glaucoma or ocular
hypertension in Korea.